We would love to hear your thoughts about our site and services, please take our survey here.
While their stake in Val is only about 300,000 pounds' worth, it still seems odd that when their website says they '...specialise in providing finances for small and medium-sized businesses...' they chose to buy on the open market rather than looking to acquire new issue shares and thus actually put fresh money into the company. Their investment doesn't help Val's financial situation one iota.
Possible nom, but then again if they fired a parting salvo that said the science and/company was a waste of space itbwould raise a few questions about board members claiming to be full of confidence and unconcerned. Maybe that will get amended to just 'unconcerned' in the coming weeks. Or maybe 'short on confidence and very concerned.'
Time will tell...
Kheldar - I think PM2022 typed it wrong. He meant to say 'I have no evidence TRX has raised the funds.'
Because he hasn't. Nor has anyone else.
So the best remedies get put aside to rot and anything less hasn't got a hope. How very bleak.
'Perhaps she isn't being whisked off elsewhere.'
Probably not when the RNS says 'today announces that Dr Sally Adams is retiring .'
If you read the RNS....
Pondering hypothetical future figures is always difficult, except when it's impossible. But it can be fun.
Genmab paid 5 million up front for one glymab to play with, and so far it seems to be going very well. Possible maximum revenue in time on that deal is over half a billion, obviously it might never get there, but at the moment it's still a possibility and technically 'on.'
5 other companies want in (potentially more as things go on, or less if some drop out of course) and initial payments could be another 5 million or so each, with (maybe) another possible half billion or more from each (plus royalties of course). So if one company wanted to shut all competition out, how much of a deal could that be? Just a nice thought for the weekend.
I love the racing car analogy - but what happens when you end up with what you tell people is a decent team, a good wingman, and the best driver, but then realise that the reason you can't get any sponsorship is because under the bodywork there isn't a howling turbocharged V12, just a small 2 stroke single with a blown head gasket and the gearbox isn't even connected. Your supporters club can sing and chant and wave banners all they like, and the team can talk earnestly about all the trophies they would like to win, but the car is as much use as a one-legged man (or woman) at a backside-kicking party.
G14 - if anything, the money of the uninvested and their presence on the board is very valuable, as they have fresh funds to invest if a sufficient facts can be produced to convince then to invest. The repetitive rampings of those who have lost massive percentages aren't conducive to buying in as there is no apparent substance to back them up.
More like False Prophets. The sort of setup which if it had toured the old west, would have seen its organisers covered in tar and feathers on a regular basis.
Do true Dracula. And to think only very recently someone posted 'Interest In Small Pharmas Is lost no matter how good the results are' and that AIM is only for trading.
If Adam is not needed in the SAB, it begs the question why he was asked, appointed or accepted in the first place. Then SD says his expertise 'is at a little later stage than many projects discussed at it.'
But doesn't that mean he has knowledge in abundance for what was needed? It's like being in hospital and saying you don't want a registrar treating you because you'd rather have a junior doctor dealing with your ailment (who probably hasn't slept for a week)
Something doesn't smell right to me in that.
201 hasn't been near a patient since before September 2020 when the results of what was arguably the slowest trial in history came out. In the RNS about it they said (word for word) 'Additional detailed analysis of the results will form the basis of peer-reviewed journal publications.'
IMO it's a matter for considerable caution that in well over three years, not a single keystroke of peer review has been achieved. Worth balancing that against PM's apparently blind faith and optimism.
PM - you say 'It is either we remain where we are or we rise big...'
There's another alternative direction which you still seem to ignore.
There have been numerous 'expert' opinions on Redmile's strategy, mainly based around the low end trader mentality - 'they'll hold for 10 percent and be out, sell now before they do' and a confident 'Redmile won't invest for more than a year.'
At least now it's got them to a 50p sell point, which is about the full value of the single Genmab deal done so far (excluding royalties).
Let's just sit and wait....
A strange message from one who claims to be a long term holder and never to have sold a single share.
If they did a 125:1 consolidation now, it would put the sp just under £6.50p, which would look impressive. Remember after one of the consolidations it was said that a share price of 36p would attract institutional investors. Unfortunately they were very savvy and amazingly saw through the smokescreen to the void behind.
On all the current evidence I think the answer is a straight 'No.'
However I'm waiting for PM to tell me that sub 5p is an excellent entry point. It's only a matter of time. Or maybe sub 4p.
PM - you might save yourself a few quid if you read your own posts and applied it to something right in front of you rather than historically on someone else's behalf.
'You can do all the research you want but that doesn't mean you don't have an agenda or understand what is going on. For example if you are burning more than you can raise, let alone commercial income a year as a company with no hint of revenue and the share price is collapsing and you keep buying and start losing significant money.'
There's none so blind as those who will not see...
Did you know that 37.6 percent of statistics are made up on the spot?
What use is a bunch of people who trust each other if they have lost faith in the company they have put money into? The orchestra on the Titanic all played in tune but the ship sank regardless.